How can I identify an abnormal neurovascular examination of the foot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Identify an Abnormal Neurovascular Examination of the Foot

An abnormal neurovascular exam of the foot is identified when you find absent 10-g monofilament sensation PLUS one other abnormal test (pinprick, temperature, vibration with 128-Hz tuning fork, or ankle reflexes) for neuropathy, OR when you detect decreased/absent pedal pulses, prolonged capillary refill, pallor on elevation, rubor on dependency, or prolonged venous filling time for vascular compromise. 1

Neurological Assessment - Identifying Loss of Protective Sensation (LOPS)

The neurological component focuses on detecting LOPS rather than early neuropathy. Here's the algorithmic approach:

Primary Test: 10-g Monofilament

  • Apply the 10-g monofilament to multiple sites on the foot
  • Absent monofilament sensation = abnormal and suggests LOPS 2, 1

Confirmatory Testing (perform at least ONE additional test):

  • Pinprick sensation - absent or diminished = abnormal
  • Temperature perception - inability to distinguish hot/cold = abnormal
  • Vibration testing with 128-Hz tuning fork - absent or diminished = abnormal
  • Ankle reflexes - absent or diminished = abnormal 3, 2, 1

Interpretation Rule:

  • LOPS is CONFIRMED: Absent monofilament sensation + at least one other abnormal test
  • LOPS is RULED OUT: At least two normal tests with NO abnormal tests 3

Vascular Assessment - Identifying Peripheral Arterial Disease (PAD)

Clinical Examination Findings (any of these = abnormal):

Pulse Assessment:

  • Decreased or absent dorsalis pedis pulse
  • Decreased or absent posterior tibial pulse 2, 1, 2

Perfusion Signs:

  • Prolonged capillary refill time (>3 seconds)
  • Rubor on dependency - redness when leg is lowered
  • Pallor on elevation - foot turns pale when elevated
  • Prolonged venous filling time 1, 4

Trophic Changes:

  • Thickened or absent toenails
  • Absence of toe hair
  • Skin atrophy 5

When to Pursue Further Testing:

If you find any of the above abnormalities OR the patient reports:

  • Leg fatigue
  • Claudication (pain with walking)
  • Rest pain relieved by dependency
  • Decreased walking speed 3

Then refer for ankle-brachial index (ABI) testing 2, 4

Critical Thresholds Indicating Severe Ischemia:

  • ABI <0.9 = PAD present
  • ABI <0.5 or ankle pressure <50 mmHg = severe ischemia requiring urgent vascular referral
  • Toe pressure <30 mmHg = limb-threatening ischemia
  • Transcutaneous oxygen pressure (TcPO2) <25 mmHg = severe ischemia 6

Common Pitfalls to Avoid:

  1. Don't rely on palpable pulses alone - A palpable pedal pulse does NOT exclude limb-threatening ischemia, especially in diabetic patients 5

  2. Don't skip the second neurological test - The monofilament alone is insufficient; you need at least one confirmatory test to properly diagnose LOPS 2, 1

  3. Beware of falsely elevated ABI - In patients with diabetes, medial arterial calcification (Mönckeberg sclerosis) can cause rigid arteries and falsely elevated ABI ≥1.3, which itself is abnormal and indicates need for alternative testing like toe pressures 7

  4. Don't dismiss asymptomatic patients - Many patients with significant PAD are asymptomatic due to concurrent neuropathy and physical inactivity 5

Skin and Structural Assessment (also part of comprehensive exam):

Abnormal findings include:

  • Skin breakdown, fissures, or ulceration
  • Foot deformities (hammertoes, bunions, prominent metatarsal heads, Charcot foot)
  • Erythema, warmth, or callus formation (indicates areas of increased pressure and impending breakdown)
  • Signs of infection 3, 2, 1

High-Risk Populations Requiring More Frequent Assessment:

Examine at EVERY visit (not just annually) if patient has:

  • Prior ulceration or amputation
  • Evidence of sensory loss (confirmed LOPS)
  • Foot deformities
  • PAD
  • Charcot foot
  • On dialysis 2, 4

Related Questions

What does it mean when the neurovascular exam is intact?
What is the differential diagnosis and physical examination approach for bilateral foot pain that does not involve the heel or arch?
How should I correctly document a neurovascular exam that is otherwise intact except for occipital numbness and tingling?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
How should carboplatin be dosed and administered in adult cancer patients, including renal function considerations, target AUC, infusion schedule, hydration, anti‑emetic prophylaxis, and monitoring?
Can apixaban (Eliquis) be used in a patient with active infective endocarditis?
A patient currently taking Adderall XR (mixed amphetamine salts) 30 mg daily wishes to switch to Focalin (dexmethylphenidate). What initial dose of Focalin is most appropriate—5 mg or 15 mg?
What is the appropriate treatment for a 17-year-old with a thickened skin blister (callus) under the hallux?
What antimicrobial regimen should be prescribed for a urine polymerase chain reaction (PCR) that identified Enterococcus faecalis resistant to mecA and sul1?
How should I adjust the trazodone regimen and manage afternoon agitation in a patient already taking trazodone 25 mg in the afternoon, sertraline 50 mg daily, and memantine 20 mg daily?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.